First-line Chemotherapy for Recurrent Cervical Cancer

NCT04188847 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Cervical Carcinoma
Persistent Advanced Cervical Carcinoma
Chemotherapy
Vascular Endothelial Growth Factor 2 Inhibitor
Apatinib
Targeted Therapy

Interventions

DRUG: Chemotherapy plus apatinib

Sponsor

Lei Li